Clinical Trial Update: A Post Market Surveillance on INFUSE Bone Graft

View source ↗

Summary

A post-market surveillance clinical trial update for INFUSE Bone Graft (rhBMP-2) sponsored by Medtronic Spinal and Biologics, currently recruiting to monitor us…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intervertebral Disc Degeneration
• Lumbar Disc Disease

Drugs mentioned

• INFUSE Bone Graft (Recombinant human bone morphogenetic protein-2 (rhBMP-2))

Snippet

Sponsor: Medtronic Spinal and Biologics | Conditions: Intervertebral Disc Degeneration, Spinal Fusion | Status: RECRUITING